Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services W. F. LemsJ. PaccouInternational Osteoporosis Foundation Fracture Working Group Position Paper Open access 21 January 2021 Pages: 399 - 411
Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials D. RosenbergT. AvniT. Diker-Cohen Review 03 November 2020 Pages: 413 - 424
C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches H. MunB. LiuQ. Wu Original Article 15 September 2020 Pages: 425 - 435
Comparing three machine learning approaches to design a risk assessment tool for future fractures: predicting a subsequent major osteoporotic fracture in fracture patients with osteopenia and osteoporosis B. C. S. de VriesJ. H. HegemanC. G. M. Groothuis-Oudshoorn Original Article 07 January 2021 Pages: 437 - 449
Exploring thoracic kyphosis and incident fracture from vertebral morphology with high-intensity exercise in middle-aged and older men with osteopenia and osteoporosis: a secondary analysis of the LIFTMOR-M trial A. T. HardingB. K. WeeksB. R. Beck Original Article 15 September 2020 Pages: 451 - 465
FRAX without BMD can be used to risk-stratify Veterans who recently sustained a low trauma non-vertebral/non-hip fracture N. SagallaC. Colón-EmericR. Lee Original Article 04 September 2020 Pages: 467 - 472
Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients L. VehmanenH. SievänenT. Saarto Original Article Open access 04 September 2020 Pages: 473 - 482
Defining an international cut-off of two-legged countermovement jump power for sarcopenia and dysmobility syndrome N. HongE. SiglinskyB. Buehring Original Article Open access 07 September 2020 Pages: 483 - 493
Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial M. OsakiR. OkudaH. Hagino Original Article Open access 23 January 2021 Pages: 495 - 503
Incidence and circumstances of falls among middle-aged women: a cohort study M. WangF. WuT. Winzenberg Original Article 12 September 2020 Pages: 505 - 513
Sleep duration and bone health measures in older men C. M. SwansonP. J. Blatchfordfor The Osteoporotic Fractures in Men (MrOS) Study Original Article 15 September 2020 Pages: 515 - 527
Psoriasis is associated with an increased risk of osteoporosis: follow-up and nested case–control studies using a national sample cohort J.W. LeeC. MinH.G. Choi Original Article 05 November 2020 Pages: 529 - 538
Reference range for 24-h urine calcium, calcium/creatinine ratio, and correlations with calcium absorption and serum vitamin D metabolites in normal women L. M. SmithJ. C. Gallagher Original Article 04 September 2020 Pages: 539 - 547
Functional electrical stimulation (FES)–assisted rowing combined with zoledronic acid, but not alone, preserves distal femur strength and stiffness in people with chronic spinal cord injury Y. FangL.R. MorseK.L. Troy Original Article 04 September 2020 Pages: 549 - 558
Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture K. ZhuJ. ZhangJ. Guan Original Article 28 September 2020 Pages: 559 - 564
Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study A. R. ZulloY. LeeS. D. Berry Original Article 07 January 2021 Pages: 565 - 573
Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling R. WinzenriethM.S. OminskyR.J. Weiss Original Article Open access 26 January 2021 Pages: 575 - 583
Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden E. SöreskogI. LindbergF. Borgström Original Article Open access 06 January 2021 Pages: 585 - 594
Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy M. HiligsmannS. MaggiJ.-Y. Reginster Original Article Open access 14 January 2021 Pages: 595 - 606
In memory of Harry K Genant C. CooperP. Halbouton behalf of the International Osteoporosis Foundation Obituary 26 January 2021 Pages: 607 - 608
Correction to: Real-world bone turnover marker use: impact on treatment decisions and fracture N. E. LaneK. SaagR. Eastell Correction Open access 19 January 2021 Pages: 609 - 609